Case Study
Zantac Lawsuit
Bellwether
The Zantac litigation has been a dynamic and evolving mass tort case, marked by significant legal developments and shifting momentum. Initially, studies in 2019 revealed that ranitidine, the active ingredient in Zantac, could degrade into NDMA, a potential carcinogen. This led to the FDA’s 2020 request to remove the drug from the market, followed by the formation of a multi-district litigation (MDL). However, a major setback occurred in 2022 when a federal judge excluded plaintiffs’ expert testimony, significantly impacting the progress of the litigation.
Despite this challenge, cases began gaining traction in state courts, particularly in California, Delaware, and Illinois. In 2023, a California judge ruled in favor of allowing expert testimony, reigniting momentum for plaintiffs. With over 70,000 cases currently pending in state courts, the litigation has seen renewed energy, culminating in settlements from major pharmaceutical companies. In 2024, both Sanofi and Pfizer agreed to settlements, and GSK announced a $2.2 billion settlement resolving 93% of claims, expected to be finalized by mid-2025. Importantly, GSK has not admitted liability as part of the agreement.
As mass tort firms navigate the complexities of these evolving cases, Aperio has played a crucial role in supporting attorneys with case workups, administrative support, and settlement submissions. Our team has been deeply involved in the Zantac litigation since 2022, ensuring that law firms have the necessary resources to efficiently manage and advance their claims.
11665
31
How We Helped
Aperio provided an end-to-end solution tailored to the needs of law firms managing Zantac claims:
-
Comprehensive Nurse Review:
Our team of experienced nurses meticulously reviewed medical records, identifying key evidence to support claims and ensuring compliance with litigation requirements.
-
Administrative Support:
We streamlined case documentation, coordinated medical record organization, and managed the high-volume workload with efficiency.
-
Settlement Portal Submissions & Deficiency Curing:
Our experts handled the complex submission process, identifying and correcting deficiencies to ensure all necessary documents were completed accurately and on time.
-
Workflow Optimization & Project Management:
We implemented structured processes to improve case tracking, ensuring law firms could efficiently manage the high caseload while prioritizing high-value claims.
Results
Aperio’s strategic support significantly enhanced the efficiency and success of the Zantac litigation process for our clients. By leveraging our expertise in nurse review and mass tort case management, we expedited the review and submission of over 11,000 cases, ensuring that attorneys could focus on legal strategy rather than administrative burdens.
Our efficient processes allowed us to deliver services at an average cost of $27.50 per case, providing a significant financial advantage to our clients.
Based on industry comparisons, our streamlined approach resulted in an estimated cost savings of $349,950 for our clients compared to competitors.
Our involvement led to increased case resolutions and alleviated law firm staff burden. With a proven track record of managing complex mass tort litigation, Aperio remains a trusted partner for law firms seeking to optimize their case management processes and achieve successful outcomes for their clients.
